| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.61 | 0.018 | 0.61 | Aldehyde oxidase inhibitor | |||
| 0.594 | 0.006 | 0.594 | Calcium channel L-type activator | 0.436 0.058 CID_154700151 | ||
| 0.578 | 0.039 | 0.578 | Caspase 9 stimulant | |||
| 0.551 | 0.014 | 0.551 | GABA C receptor rho-3 antagonist | 0.229 0.174 CID_154700151 | ||
| 0.515 | 0.006 | 0.515 | Topoisomerase II inhibitor | 0.153 0.048 CID_154700151 | ||
| 0.546 | 0.061 | 0.546 | Apoptosis agonist | |||
| 0.487 | 0.005 | 0.487 | DNA intercalator | 0.234 0.018 CID_154700151 | ||
| 0.463 | 0.004 | 0.463 | Cystathionine beta-synthase inhibitor | 0.104 0.073 CID_154700151 | ||
| 0.444 | 0.008 | 0.444 | Mcl-1 antagonist | |||
| 0.439 | 0.015 | 0.439 | Peroxidase inhibitor | 0.136 0.086 CID_154700151 | ||
| 0.46 | 0.055 | 0.46 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.284 0.235 CID_154700151 | ||
| 0.429 | 0.032 | 0.429 | 12-Lipoxygenase inhibitor | |||
| 0.448 | 0.052 | 0.448 | 5 Hydroxytryptamine release inhibitor | |||
| 0.398 | 0.005 | 0.398 | Estrogen antagonist | 0.118 0.059 CID_154700151 | ||
| 0.405 | 0.023 | 0.405 | Calcium channel activator | 0.239 0.16 CID_154700151 | ||
| 0.385 | 0.004 | 0.385 | Estrogen receptor beta antagonist | 0.11 0.047 CID_154700151 | ||
| 0.406 | 0.027 | 0.406 | DNA damaging | |||
| 0.431 | 0.059 | 0.431 | Histamine release inhibitor | 0.385 0.083 CID_154700151 | ||
| 0.397 | 0.031 | 0.397 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.368 | 0.005 | 0.368 | Topoisomerase II alpha inhibitor | |||
| 0.38 | 0.018 | 0.38 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.393 | 0.039 | 0.393 | Lipoxygenase inhibitor | |||
| 0.367 | 0.013 | 0.367 | Tyrosine 3 hydroxylase inhibitor | 0.187 0.161 CID_154700151 | ||
| 0.379 | 0.024 | 0.379 | Sodium/bile acid cotransporter inhibitor | 0.337 0.049 CID_154700151 | ||
| 0.412 | 0.07 | 0.412 | 15-Lipoxygenase inhibitor | 0.298 0.133 CID_154700151 | ||
| 0.349 | 0.009 | 0.349 | Neurotrophic factor enhancer | |||
| 0.361 | 0.023 | 0.419 | RNA-directed DNA polymerase inhibitor | 0.419 0.016 CID_154700151 | CID_154700151 | |
| 0.385 | 0.051 | 0.385 | Streptokinase A inhibitor | |||
| 0.395 | 0.064 | 0.395 | Transcription factor NF kappa B inhibitor | 0.213 0.157 CID_154700151 | ||
| 0.359 | 0.028 | 0.359 | DNA synthesis inhibitor | 0.207 0.112 CID_154700151 | ||
| 0.394 | 0.065 | 0.394 | Immunosuppressant | 0.246 0.151 CID_154700151 | ||
| 0.333 | 0.015 | 0.333 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.326 | 0.009 | 0.326 | Topoisomerase I inhibitor | 0.132 0.049 CID_154700151 | ||
| 0.363 | 0.047 | 0.363 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.32 | 0.005 | 0.32 | Estrogen receptor alpha antagonist | 0.072 0.062 CID_154700151 | ||
| 0.345 | 0.04 | 0.345 | Free radical scavenger | |||
| 0.314 | 0.01 | 0.314 | Aldehyde dehydrogenase inhibitor | |||
| 0.383 | 0.084 | 0.43 | Antibacterial | 0.43 0.064 CID_154700151 | CID_154700151 | |
| 0.338 | 0.05 | 0.357 | Antioxidant | 0.357 0.044 CID_154700151 | CID_154700151 | |
| 0.347 | 0.065 | 0.496 | Cholesterol antagonist | 0.496 0.033 CID_154700151 | CID_154700151 | |
| 0.411 | 0.133 | 0.411 | Antiinflammatory | 0.347 0.175 CID_154700151 | ||
| 0.329 | 0.067 | 0.329 | Apoptosis antagonist | |||
| 0.269 | 0.009 | 0.269 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.263 | 0.017 | 0.263 | Heat shock protein 90 antagonist | |||
| 0.255 | 0.01 | 0.255 | Catenin beta inhibitor | |||
| 0.308 | 0.067 | 0.308 | 5 Hydroxytryptamine release stimulant | |||
| 0.291 | 0.05 | 0.291 | Pyruvate kinase inhibitor | |||
| 0.262 | 0.022 | 0.262 | Histone acetyltransferase inhibitor | |||
| 0.329 | 0.09 | 0.329 | Prostaglandin dehydrogenase inhibitor | |||
| 0.259 | 0.021 | 0.259 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.247 | 0.01 | 0.247 | Telomerase inhibitor | |||
| 0.291 | 0.054 | 0.405 | Superoxide dismutase inhibitor | 0.405 0.026 CID_154700151 | CID_154700151 | |
| 0.24 | 0.005 | 0.24 | CYP2A6 inhibitor | |||
| 0.256 | 0.024 | 0.256 | Heat shock protein 90 alpha antagonist | |||
| 0.235 | 0.005 | 0.235 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.233 | 0.007 | 0.233 | Creatine kinase inhibitor | 0.119 0.042 CID_154700151 | ||
| 0.288 | 0.063 | 0.288 | Transcription factor STAT inhibitor | |||
| 0.239 | 0.016 | 0.239 | ATPase inhibitor | |||
| 0.245 | 0.028 | 0.245 | Lipid peroxidase inhibitor | 0.139 0.076 CID_154700151 | ||
| 0.236 | 0.018 | 0.236 | Alkylator | 0.163 0.04 CID_154700151 | ||
| 0.224 | 0.01 | 0.224 | Porphobilinogen synthase inhibitor | 0.082 0.046 CID_154700151 | ||
| 0.24 | 0.026 | 0.24 | Succinate dehydrogenase inhibitor | 0.166 0.086 CID_154700151 | ||
| 0.222 | 0.008 | 0.406 | HIV-1 integrase (3'-Processing) inhibitor | 0.406 0.004 CID_154700151 | CID_154700151 | |
| 0.271 | 0.065 | 0.271 | Hypoglycemic | |||
| 0.213 | 0.008 | 0.213 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.068 0.063 CID_154700151 | ||
| 0.234 | 0.035 | 0.607 | Protein-tyrosine phosphatase inhibitor | 0.607 0.004 CID_154700151 | CID_154700151 | |
| 0.244 | 0.045 | 0.244 | Non-steroidal antiinflammatory agent | |||
| 0.256 | 0.061 | 0.256 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.203 | 0.012 | 0.203 | Photosensitizer | 0.121 0.056 CID_154700151 | ||
| 0.196 | 0.007 | 0.29 | CDC25A inhibitor | 0.29 0.004 CID_154700151 | CID_154700151 | |
| 0.193 | 0.004 | 0.193 | Ca2+-transporting ATPase inhibitor | 0.136 0.091 CID_154700151 | ||
| 0.215 | 0.027 | 0.215 | Hexokinase inhibitor | |||
| 0.208 | 0.025 | 0.208 | GABA C receptor rho-2 antagonist | |||
| 0.193 | 0.013 | 0.193 | Alcohol dehydrogenase inhibitor | |||
| 0.2 | 0.022 | 0.2 | Ferrochelatase inhibitor | |||
| 0.213 | 0.036 | 0.213 | Melanin inhibitor | |||
| 0.198 | 0.021 | 0.198 | Antineoplastic antibiotic | 0.1 0.046 CID_154700151 | ||
| 0.181 | 0.005 | 0.263 | HIV-1 integrase inhibitor | 0.263 0.004 CID_154700151 | CID_154700151 | |
| 0.216 | 0.041 | 0.216 | 5 Hydroxytryptamine 3E antagonist | 0.173 0.125 CID_154700151 | ||
| 0.198 | 0.025 | 0.198 | 5-Lipoxygenase inhibitor | |||
| 0.209 | 0.038 | 0.209 | Interferon gamma antagonist | |||
| 0.202 | 0.031 | 0.202 | Arachidonic acid antagonist | 0.129 0.113 CID_154700151 | ||
| 0.195 | 0.025 | 0.195 | CF transmembrane conductance regulator agonist | |||
| 0.187 | 0.017 | 0.187 | Antineoplastic alkaloid | |||
| 0.177 | 0.009 | 0.34 | Estrogen agonist | 0.34 0.005 CID_154700151 | CID_154700151 | |
| 0.185 | 0.022 | 0.185 | Adenylate cyclase stimulant | 0.171 0.034 CID_154700151 | ||
| 0.168 | 0.006 | 0.173 | Estrogen receptor beta agonist | 0.173 0.005 CID_154700151 | CID_154700151 | |
| 0.17 | 0.009 | 0.17 | Phenylalanine 4-hydroxylase inhibitor | 0.064 0.053 CID_154700151 | ||
| 0.22 | 0.061 | 0.22 | Nitric-oxide synthase stimulant | |||
| 0.244 | 0.086 | 0.244 | Gastrin inhibitor | |||
| 0.239 | 0.084 | 0.239 | Aryl hydrocarbon receptor agonist | |||
| 0.16 | 0.004 | 0.16 | Fatty acid synthase inhibitor | |||
| 0.18 | 0.025 | 0.18 | GABA C receptor agonist | |||
| 0.259 | 0.105 | 0.259 | Caspase 3 stimulant | |||
| 0.175 | 0.022 | 0.175 | UDP-glucose 4-epimerase inhibitor | |||
| 0.212 | 0.062 | 0.212 | Insulin sensitizer | |||
| 0.168 | 0.019 | 0.168 | DNA repair enzyme inhibitor | |||
| 0.207 | 0.06 | 0.207 | LIM domain kinase 1 inhibitor | |||
| 0.189 | 0.042 | 0.189 | Neurotensin receptor agonist | |||
| 0.16 | 0.015 | 0.16 | ABCA1 expression enhancer | 0.098 0.053 CID_154700151 | ||
| 0.222 | 0.08 | 0.222 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.191 | 0.05 | 0.221 | Phospholipase C inhibitor | 0.221 0.033 CID_154700151 | CID_154700151 | |
| 0.161 | 0.021 | 0.161 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.067 CID_154700151 | ||
| 0.187 | 0.049 | 0.187 | Amylase inhibitor | |||
| 0.22 | 0.082 | 0.22 | Hypolipemic | 0.172 0.116 CID_154700151 | ||
| 0.143 | 0.006 | 0.143 | D-Ala-D-Ala ligase inhibitor | |||
| 0.138 | 0.006 | 0.138 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 CID_154700151 | ||
| 0.141 | 0.011 | 0.141 | T cell inhibitor | |||
| 0.156 | 0.027 | 0.156 | GABA C receptor antagonist | 0.117 0.056 CID_154700151 | ||
| 0.151 | 0.023 | 0.151 | Transcription factor STAT6 inhibitor | |||
| 0.153 | 0.027 | 0.153 | Potassium channel (Ca-activated) activator | |||
| 0.166 | 0.042 | 0.166 | Toll-Like receptor 2 antagonist | |||
| 0.175 | 0.053 | 0.175 | Protein kinase stimulant | |||
| 0.198 | 0.076 | 0.198 | Anesthetic general | |||
| 0.148 | 0.025 | 0.148 | CC chemokine 6 receptor antagonist | |||
| 0.154 | 0.033 | 0.154 | Xanthine oxidase inhibitor | |||
| 0.226 | 0.105 | 0.226 | Transcription factor STAT3 inhibitor | |||
| 0.144 | 0.025 | 0.144 | DOPA decarboxylase inhibitor | |||
| 0.133 | 0.014 | 0.469 | HIV-1 integrase (Strand Transfer) inhibitor | 0.469 0.003 CID_154700151 | CID_154700151 | |
| 0.159 | 0.044 | 0.159 | Monophenol monooxygenase inhibitor | |||
| 0.163 | 0.047 | 0.163 | NADPH oxidase inhibitor | |||
| 0.141 | 0.026 | 0.141 | Prolactin inhibitor | |||
| 0.213 | 0.098 | 0.213 | Neuropeptide Y2 antagonist | |||
| 0.131 | 0.016 | 0.131 | Glutamate release inhibitor | |||
| 0.147 | 0.033 | 0.147 | Protein kinase C gamma inhibitor | |||
| 0.155 | 0.042 | 0.209 | Cholesterol synthesis inhibitor | 0.209 0.025 CID_154700151 | CID_154700151 | |
| 0.137 | 0.024 | 0.353 | Triose-phosphate isomerase inhibitor | 0.353 0.004 CID_154700151 | CID_154700151 | |
| 0.132 | 0.022 | 0.132 | Histamine N-methyltransferase inhibitor | |||
| 0.162 | 0.053 | 0.162 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.143 | 0.033 | 0.143 | Carbonic anhydrase XV inhibitor | 0.1 0.067 CID_154700151 | ||
| 0.132 | 0.023 | 0.132 | NADH dehydrogenase inhibitor | 0.082 0.071 CID_154700151 | ||
| 0.12 | 0.011 | 0.12 | CDC25B inhibitor | |||
| 0.146 | 0.037 | 0.146 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.199 | 0.091 | 0.199 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.278 | 0.171 | 0.278 | Alpha-glucosidase inhibitor | |||
| 0.151 | 0.045 | 0.454 | Protein-tyrosine phosphatase 1B inhibitor | 0.454 0.005 CID_154700151 | CID_154700151 | |
| 0.135 | 0.029 | 0.135 | GABA C receptor rho-1 antagonist | |||
| 0.155 | 0.05 | 0.155 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.119 | 0.014 | 0.119 | Alcohol oxidase inhibitor | |||
| 0.239 | 0.135 | 0.344 | Antithrombotic | 0.344 0.067 CID_154700151 | CID_154700151 | |
| 0.121 | 0.018 | 0.153 | Glycine receptor antagonist | 0.153 0.007 CID_154700151 | CID_154700151 | |
| 0.225 | 0.122 | 0.225 | Insulysin inhibitor | |||
| 0.2 | 0.098 | 0.2 | Dyrk kinase inhibitor | |||
| 0.131 | 0.03 | 0.148 | Anabolic | 0.148 0.019 CID_154700151 | CID_154700151 | |
| 0.133 | 0.033 | 0.133 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.108 | 0.008 | 0.108 | CD45 antagonist | |||
| 0.146 | 0.047 | 0.146 | Adenylate cyclase inhibitor | |||
| 0.21 | 0.112 | 0.21 | Interleukin agonist | |||
| 0.241 | 0.143 | 0.241 | Vasodilator, coronary | |||
| 0.147 | 0.052 | 0.147 | Heat shock protein 70 antagonist | |||
| 0.138 | 0.043 | 0.138 | 5 Hydroxytryptamine 3A agonist | |||
| 0.11 | 0.016 | 0.11 | Glycine receptor agonist | |||
| 0.126 | 0.034 | 0.126 | Uric acid excretion stimulant | |||
| 0.129 | 0.038 | 0.129 | Beta glucuronidase inhibitor | |||
| 0.174 | 0.084 | 0.174 | DNA methyltransferase I inhibitor | |||
| 0.1 | 0.011 | 0.1 | Heat shock protein 90 beta antagonist | |||
| 0.157 | 0.068 | 0.157 | Phospholipase A2 inhibitor | 0.119 0.118 CID_154700151 | ||
| 0.107 | 0.018 | 0.107 | Estrogen-related receptor beta agonist | |||
| 0.11 | 0.024 | 0.11 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.093 | 0.007 | 0.093 | DNA helicase inhibitor | |||
| 0.112 | 0.026 | 0.112 | ATPase (Vacuolar H+) inhibitor | |||
| 0.124 | 0.04 | 0.124 | Adenylate kinase inhibitor | |||
| 0.1 | 0.016 | 0.1 | Purinergic P2X1 antagonist | |||
| 0.093 | 0.009 | 0.093 | Estrogen receptor alpha agonist | |||
| 0.108 | 0.026 | 0.108 | Glutamate decarboxylase inhibitor | |||
| 0.149 | 0.067 | 0.149 | Activin receptor-like kinase 2 inhibitor | |||
| 0.141 | 0.059 | 0.141 | Interleukin 4 antagonist | |||
| 0.088 | 0.006 | 0.088 | Retinoid X receptor agonist | |||
| 0.09 | 0.009 | 0.09 | Liver X receptor agonist | |||
| 0.092 | 0.011 | 0.092 | Topoisomerase II beta inhibitor | |||
| 0.206 | 0.125 | 0.206 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.088 | 0.008 | 0.088 | Bcl-xL inhibitor | |||
| 0.125 | 0.045 | 0.125 | AMP-activated protein kinase stimulant | |||
| 0.164 | 0.085 | 0.164 | Nitric oxide antagonist | |||
| 0.09 | 0.01 | 0.09 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.143 | 0.064 | 0.143 | Alkaline phosphatase inhibitor | 0.135 0.072 CID_154700151 | ||
| 0.161 | 0.083 | 0.447 | Dual specificity phosphatase inhibitor | 0.447 0.01 CID_154700151 | CID_154700151 | |
| 0.092 | 0.014 | 0.092 | Glutamate (mGluR6) antagonist | |||
| 0.129 | 0.051 | 0.129 | Microtubule formation inhibitor | |||
| 0.143 | 0.066 | 0.143 | Pregnane X receptor agonist | |||
| 0.082 | 0.005 | 0.082 | Liver X receptor antagonist | |||
| 0.102 | 0.025 | 0.102 | GABA aminotransferase inhibitor | |||
| 0.124 | 0.047 | 0.124 | Activin receptor-like kinase 4 inhibitor | |||
| 0.1 | 0.026 | 0.1 | Leukotriene synthesis inhibitor | |||
| 0.138 | 0.065 | 0.138 | Cyclooxygenase 1 inhibitor | 0.126 0.075 CID_154700151 | ||
| 0.08 | 0.007 | 0.08 | Pregnane X receptor antagonist | |||
| 0.077 | 0.004 | 0.077 | ATP citrate lysase inhibitor | |||
| 0.118 | 0.046 | 0.118 | Carbonic anhydrase III inhibitor | 0.094 0.069 CID_154700151 | ||
| 0.123 | 0.052 | 0.123 | Mucolytic | |||
| 0.1 | 0.029 | 0.1 | Thioredoxin reductase inhibitor | |||
| 0.222 | 0.152 | 0.222 | Vasodilator, peripheral | |||
| 0.077 | 0.008 | 0.077 | Retinoid X alpha receptor agonist | |||
| 0.072 | 0.004 | 0.072 | Liver X receptor alpha antagonist | |||
| 0.078 | 0.014 | 0.078 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.13 | 0.067 | 0.13 | Cyclooxygenase 3 inhibitor | |||
| 0.108 | 0.045 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.076 | 0.013 | 0.076 | Potassium channel Kv1.3 blocker | |||
| 0.143 | 0.08 | 0.143 | NOS3 expression enhancer | |||
| 0.132 | 0.069 | 0.345 | Tubulin antagonist | 0.345 0.015 CID_154700151 | CID_154700151 | |
| 0.106 | 0.044 | 0.172 | Protein kinase C zeta inhibitor | 0.172 0.015 CID_154700151 | CID_154700151 | |
| 0.086 | 0.023 | 0.086 | Biliverdin reductase inhibitor | |||
| 0.071 | 0.009 | 0.071 | Liver X receptor alpha agonist | |||
| 0.078 | 0.016 | 0.078 | Calcium channel P-type blocker | |||
| 0.087 | 0.025 | 0.109 | Phospholipase D inhibitor | 0.109 0.01 CID_154700151 | CID_154700151 | |
| 0.07 | 0.008 | 0.07 | Dopamine D5 agonist | |||
| 0.1 | 0.038 | 0.176 | Catalase inhibitor | 0.176 0.02 CID_154700151 | CID_154700151 | |
| 0.069 | 0.007 | 0.069 | GABA uptake inhibitor | |||
| 0.12 | 0.059 | 0.12 | TRPA1 agonist | 0.116 0.063 CID_154700151 | ||
| 0.085 | 0.025 | 0.085 | Aromatase inhibitor | |||
| 0.088 | 0.028 | 0.088 | MAP kinase kinase 7 inhibitor | |||
| 0.1 | 0.041 | 0.1 | Bromodomain-containing protein 2 inhibitor | |||
| 0.082 | 0.024 | 0.082 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.102 | 0.045 | 0.106 | Bile acid receptor antagonist | 0.106 0.038 CID_154700151 | CID_154700151 | |
| 0.092 | 0.035 | 0.092 | Phosphofructokinase-1 inhibitor | |||
| 0.084 | 0.028 | 0.536 | Beta tubulin antagonist | 0.536 0.004 CID_154700151 | CID_154700151 | |
| 0.091 | 0.035 | 0.091 | CC chemokine 5 receptor agonist | 0.081 0.063 CID_154700151 | ||
| 0.071 | 0.016 | 0.071 | Dihydroorotate oxidase inhibitor | |||
| 0.086 | 0.031 | 0.086 | GABA B receptor agonist | |||
| 0.164 | 0.109 | 0.164 | Focal adhesion kinase 2 inhibitor | |||
| 0.135 | 0.081 | 0.238 | Cell wall synthesis inhibitor | 0.238 0.018 CID_154700151 | CID_154700151 | |
| 0.075 | 0.023 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.091 | 0.038 | 0.091 | Interferon agonist | 0.075 0.061 CID_154700151 | ||
| 0.126 | 0.074 | 0.126 | Vanilloid 1 agonist | |||
| 0.078 | 0.027 | 0.078 | NMDA 2C receptor antagonist | 0.063 0.041 CID_154700151 | ||
| 0.16 | 0.109 | 0.16 | DNA methylase inhibitor | |||
| 0.098 | 0.048 | 0.098 | Androgen antagonist | |||
| 0.15 | 0.1 | 0.15 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.136 | 0.087 | 0.136 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.109 | 0.059 | 0.109 | Expectorant | |||
| 0.062 | 0.013 | 0.062 | Urate transporter 1 inhibitor | |||
| 0.058 | 0.009 | 0.058 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.055 | 0.006 | 0.055 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.082 | 0.034 | 0.082 | Potassium channel large-conductance Ca-activated activator | |||
| 0.079 | 0.032 | 0.079 | Protein kinase C beta inhibitor | |||
| 0.069 | 0.022 | 0.069 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.077 | 0.031 | 0.077 | Glutamate (mGluR7) antagonist | |||
| 0.129 | 0.083 | 0.129 | Nav1.6 sodium channel blocker | |||
| 0.058 | 0.012 | 0.058 | Alpha 1d adrenoreceptor agonist | |||
| 0.095 | 0.05 | 0.095 | Ornithine decarboxylase inhibitor | |||
| 0.081 | 0.036 | 0.081 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.055 | 0.011 | 0.055 | Angiotensin AT1 receptor antagonist | |||
| 0.085 | 0.041 | 0.085 | Glutamate dehydrogenase inhibitor | |||
| 0.052 | 0.008 | 0.052 | Liver X receptor beta antagonist | |||
| 0.11 | 0.066 | 0.11 | GABA receptor agonist | |||
| 0.13 | 0.087 | 0.13 | Cyclooxygenase inhibitor | |||
| 0.066 | 0.023 | 0.066 | 5 Hydroxytryptamine 7 agonist | |||
| 0.085 | 0.042 | 0.085 | Keratolytic | |||
| 0.061 | 0.018 | 0.061 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.071 | 0.029 | 0.071 | Transcription factor RelA inhibitor | |||
| 0.071 | 0.03 | 0.071 | Androgen agonist | 0.06 0.041 CID_154700151 | ||
| 0.076 | 0.035 | 0.076 | Dopamine D1 antagonist | |||
| 0.054 | 0.014 | 0.054 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.086 | 0.046 | 0.086 | Phosphodiesterase 3A inhibitor | |||
| 0.051 | 0.012 | 0.051 | Retinoid X receptor antagonist | |||
| 0.066 | 0.027 | 0.066 | Alpha tubulin antagonist | |||
| 0.063 | 0.024 | 0.063 | Aconitate hydratase inhibitor | |||
| 0.12 | 0.081 | 0.12 | Antibacterial (Helicobacter pylori) | |||
| 0.068 | 0.029 | 0.068 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.058 | 0.019 | 0.058 | Adenylate cyclase 1 inhibitor | |||
| 0.102 | 0.064 | 0.15 | Aminopeptidase B inhibitor | 0.15 0.038 CID_154700151 | CID_154700151 | |
| 0.077 | 0.039 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.055 | 0.018 | 0.055 | Geranyltranstransferase inhibitor | |||
| 0.056 | 0.019 | 0.056 | Dihydroorotase inhibitor | |||
| 0.079 | 0.043 | 0.079 | Aminopeptidase I inhibitor | |||
| 0.083 | 0.047 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 CID_154700151 | CID_154700151 | |
| 0.067 | 0.031 | 0.067 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.087 | 0.052 | 0.087 | GABA A receptor agonist | |||
| 0.097 | 0.063 | 0.097 | Sphingomyelinase inhibitor | |||
| 0.122 | 0.087 | 0.122 | Cytokine production inhibitor | 0.11 0.1 CID_154700151 | ||
| 0.097 | 0.062 | 0.097 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.072 | 0.039 | 0.072 | Exportin-1 inhibitor | |||
| 0.117 | 0.083 | 0.117 | Cyclooxygenase 2 inhibitor | |||
| 0.072 | 0.039 | 0.072 | Bcl2 antagonist | |||
| 0.043 | 0.011 | 0.043 | Angiotensin II receptor antagonist | |||
| 0.038 | 0.006 | 0.055 | Dopamine D1 agonist | 0.055 0.004 CID_154700151 | CID_154700151 | |
| 0.054 | 0.022 | 0.054 | NMDA receptor subunit 3B antagonist | |||
| 0.068 | 0.036 | 0.068 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.043 | 0.012 | 0.043 | Retinoid X alpha receptor antagonist | |||
| 0.047 | 0.016 | 0.047 | Retinoic acid alpha receptor agonist | |||
| 0.042 | 0.011 | 0.046 | Cholesterol ester transfer protein antagonist | 0.046 0.009 CID_154700151 | CID_154700151 | |
| 0.108 | 0.077 | 0.108 | Proteasome inhibitor | |||
| 0.068 | 0.038 | 0.068 | Interferon inducer | |||
| 0.076 | 0.046 | 0.076 | Histidine decarboxylase inhibitor | |||
| 0.042 | 0.014 | 0.042 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.105 | 0.077 | 0.156 | Acetylcholine release stimulant | 0.156 0.013 CID_154700151 | CID_154700151 | |
| 0.043 | 0.016 | 0.043 | Vanilloid 3 antagonist | |||
| 0.051 | 0.024 | 0.051 | Phosphodiesterase 3B inhibitor | |||
| 0.116 | 0.089 | 0.116 | Bone formation stimulant | |||
| 0.085 | 0.058 | 0.085 | mTOR complex 2 inhibitor | |||
| 0.049 | 0.022 | 0.058 | Guanylate cyclase inhibitor | 0.058 0.014 CID_154700151 | CID_154700151 | |
| 0.152 | 0.125 | 0.152 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.058 | 0.031 | 0.058 | NMDA 2A receptor antagonist | |||
| 0.094 | 0.068 | 0.094 | MAO A inhibitor | |||
| 0.057 | 0.031 | 0.057 | Immunoglobulin Fc receptor antagonist | |||
| 0.057 | 0.031 | 0.057 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.042 | 0.016 | 0.042 | Sirtuin 2 inhibitor | |||
| 0.047 | 0.021 | 0.047 | NMDA receptor subunit 3A antagonist | |||
| 0.089 | 0.064 | 0.089 | Protein kinase C delta inhibitor | |||
| 0.126 | 0.102 | 0.394 | Hemostatic | 0.394 0.008 CID_154700151 | CID_154700151 | |
| 0.04 | 0.016 | 0.04 | Free fatty acid receptor 1 antagonist | |||
| 0.027 | 0.004 | 0.027 | Antibiotic Anthracycline-like | |||
| 0.059 | 0.037 | 0.059 | Argininosuccinate synthase inhibitor | |||
| 0.06 | 0.038 | 0.06 | Xanthine dehydrogenase inhibitor | |||
| 0.031 | 0.009 | 0.031 | Vanilloid 2 agonist | 0.028 0.012 CID_154700151 | ||
| 0.038 | 0.017 | 0.038 | HMG CoA reductase inhibitor | |||
| 0.073 | 0.052 | 0.073 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.055 | 0.034 | 0.058 | Leukotriene B4 antagonist | 0.058 0.03 CID_154700151 | CID_154700151 | |
| 0.049 | 0.03 | 0.049 | Thymidylate synthase inhibitor | |||
| 0.062 | 0.044 | 0.062 | NMDA receptor glycine site agonist | |||
| 0.058 | 0.04 | 0.058 | Botulinum neurotoxin type A inhibitor | |||
| 0.061 | 0.043 | 0.061 | Heme oxygenase stimulant | |||
| 0.036 | 0.019 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.03 | 0.013 | 0.03 | Hedgehog signaling activator | |||
| 0.031 | 0.014 | 0.031 | Estrogen-related receptor gamma antagonist | |||
| 0.05 | 0.033 | 0.05 | Squalene epoxidase inhibitor | |||
| 0.068 | 0.051 | 0.068 | Prostaglandin-E synthase inhibitor | |||
| 0.041 | 0.024 | 0.041 | CF transmembrane conductance regulator antagonist | |||
| 0.036 | 0.019 | 0.036 | Liver X receptor beta agonist | |||
| 0.044 | 0.027 | 0.044 | Nerve growth factor antagonist | |||
| 0.061 | 0.045 | 0.061 | Phosphodiesterase 1C inhibitor | |||
| 0.055 | 0.039 | 0.096 | Adenine nucleotide translocase inhibitor | 0.096 0.005 CID_154700151 | CID_154700151 | |
| 0.029 | 0.014 | 0.029 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.024 | 0.008 | 0.024 | Retinoid X beta receptor antagonist | |||
| 0.038 | 0.023 | 0.038 | Progesterone antagonist | |||
| 0.063 | 0.048 | 0.063 | Beta 3 adrenoreceptor antagonist | |||
| 0.077 | 0.062 | 0.077 | Carbonic anhydrase VI inhibitor | |||
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.125 | 0.11 | 0.125 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.025 | 0.011 | 0.025 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.056 | 0.042 | 0.056 | Plasminogen activator inhibitor | |||
| 0.074 | 0.06 | 0.074 | Macrophage migration inhibitory factor inhibitor | |||
| 0.034 | 0.021 | 0.034 | Melatonin 2 agonist | |||
| 0.129 | 0.116 | 0.129 | MAP kinase kinase 4 inhibitor | |||
| 0.033 | 0.021 | 0.033 | Estrogen-related receptor beta antagonist | |||
| 0.058 | 0.045 | 0.058 | Phosphodiesterase 1B inhibitor | |||
| 0.036 | 0.024 | 0.036 | Ceramide glucosyltransferase inhibitor | |||
| 0.083 | 0.071 | 0.083 | Phosphodiesterase I inhibitor | |||
| 0.035 | 0.023 | 0.035 | RNA-directed RNA polymerase inhibitor | |||
| 0.02 | 0.009 | 0.02 | Alpha 2a adrenoreceptor agonist | |||
| 0.032 | 0.021 | 0.032 | HCV NS5B polymerase inhibitor | |||
| 0.051 | 0.041 | 0.051 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.106 | 0.096 | 0.106 | Cathepsin H inhibitor | |||
| 0.049 | 0.039 | 0.049 | 5 Hydroxytryptamine 2 agonist | |||
| 0.067 | 0.058 | 0.182 | Cathepsin G inhibitor | 0.182 0.017 CID_154700151 | CID_154700151 | |
| 0.094 | 0.086 | 0.094 | Chelator | |||
| 0.083 | 0.074 | 0.083 | Thioredoxin inhibitor | |||
| 0.088 | 0.079 | 0.088 | Electrolyte absorption antagonist | |||
| 0.137 | 0.129 | 0.137 | Psychostimulant | |||
| 0.037 | 0.029 | 0.037 | Glutamate (mGluR8) agonist | |||
| 0.04 | 0.032 | 0.04 | Kainate receptor agonist | |||
| 0.025 | 0.017 | 0.025 | Complement factor 1s inhibitor | |||
| 0.06 | 0.053 | 0.06 | Aryl hydrocarbon receptor antagonist | |||
| 0.123 | 0.116 | 0.123 | Neuropeptide Y1 antagonist | |||
| 0.029 | 0.022 | 0.029 | Factor VII inhibitor | |||
| 0.012 | 0.005 | 0.012 | Progesterone receptor A antagonist | |||
| 0.06 | 0.053 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.035 CID_154700151 | CID_154700151 | |
| 0.016 | 0.009 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.044 | 0.038 | 0.044 | Aldosterone antagonist | |||
| 0.025 | 0.019 | 0.025 | Sodium/glucose cotransporter inhibitor | |||
| 0.07 | 0.064 | 0.07 | Vanilloid 4 agonist | |||
| 0.017 | 0.012 | 0.017 | Telomerase stimulant | |||
| 0.057 | 0.053 | 0.057 | I kappa B kinase 2 inhibitor | |||
| 0.136 | 0.132 | 0.463 | Angiogenesis stimulant | 0.463 0.014 CID_154700151 | CID_154700151 | |
| 0.05 | 0.046 | 0.05 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.109 | 0.106 | 0.109 | Interleukin 1 antagonist | |||
| 0.033 | 0.03 | 0.033 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.03 | 0.028 | 0.03 | Glutamate (mGluR3) agonist | |||
| 0.037 | 0.035 | 0.037 | Acid-sensing ion channel blocker | |||
| 0.04 | 0.038 | 0.04 | Sphingosine 1-phosphate receptor agonist | |||
| 0.011 | 0.01 | 0.011 | Egl nine homolog 3 inhibitor | |||
| 0.045 | 0.044 | 0.045 | Aldose reductase inhibitor | |||
| 0.04 | 0.039 | 0.04 | Glutamate (mGluR group III) antagonist | |||
| 0.062 | 0.06 | 0.077 | NMDA 2 receptor antagonist | 0.077 0.045 CID_154700151 | CID_154700151 | |
| 0.03 | 0.028 | 0.03 | Catechol O-methyltransferase inhibitor | |||
| 0.024 | 0.023 | 0.028 | Thyroid hormone agonist | 0.028 0.015 CID_154700151 | CID_154700151 | |
| 0.029 | 0.028 | 0.029 | Melatonin agonist | |||
| 0.019 | 0.02 | 0.066 | Glutamate (mGluR1a) agonist | 0.066 0.004 CID_154700151 | CID_154700151 | |
| 0.055 | 0.056 | 0.059 | NMDA receptor agonist | 0.059 0.049 CID_154700151 | CID_154700151 | |
| 0.047 | 0.048 | 0.1 | Carbonic anhydrase VB inhibitor | 0.1 0.016 CID_154700151 | CID_154700151 | |
| 0.048 | 0.052 | 0.078 | Heparanase inhibitor | 0.078 0.007 CID_154700151 | CID_154700151 | |
| 0.075 | 0.089 | 0.155 | Breast cancer-resistant protein inhibitor | 0.155 0.022 CID_154700151 | CID_154700151 | |
| 0.044 | 0.058 | 0.057 | Alpha-mannosidase inhibitor | 0.057 0.031 CID_154700151 | CID_154700151 | |
| 0.124 | 0.143 | 0.17 | Hepatoprotectant | 0.17 0.089 CID_154700151 | CID_154700151 | |
| 0.223 | 0.243 | 0.503 | Cyclophilin D inhibitor | 0.503 0.049 CID_154700151 | CID_154700151 | |
| 0.056 | 0.076 | 0.186 | Carbonic anhydrase XIII inhibitor | 0.186 0.016 CID_154700151 | CID_154700151 | |
| 0.142 | 0.162 | 0.215 | Immunostimulant | 0.215 0.111 CID_154700151 | CID_154700151 | |
| 0.013 | 0.033 | 0.076 | Estrone sulfatase inhibitor | 0.076 0.005 CID_154700151 | CID_154700151 | |
| 0.053 | 0.074 | 0.134 | Carbonic anhydrase VA inhibitor | 0.134 0.014 CID_154700151 | CID_154700151 | |
| 0.048 | 0.07 | 0.059 | Sphingosine kinase inhibitor | 0.059 0.04 CID_154700151 | CID_154700151 | |
| 0.025 | 0.047 | 0.063 | Purinergic P2Y2 antagonist | 0.063 0.007 CID_154700151 | CID_154700151 | |
| 0.049 | 0.071 | 0.186 | Carbonic anhydrase V inhibitor | 0.186 0.008 CID_154700151 | CID_154700151 | |
| 0.087 | 0.112 | 0.096 | Nav1.5 sodium channel blocker | 0.096 0.093 CID_154700151 | CID_154700151 | |
| 0.031 | 0.063 | 0.044 | Mannosidase inhibitor | 0.044 0.033 CID_154700151 | CID_154700151 | |
| 0.017 | 0.052 | 0.025 | Glutamate (mGluR1) agonist | 0.025 0.016 CID_154700151 | CID_154700151 | |
| 0.092 | 0.128 | 0.113 | Nav1.2 sodium channel blocker | 0.113 0.092 CID_154700151 | CID_154700151 | |
| 0.06 | 0.1 | 0.095 | Cell adhesion molecule inhibitor | 0.095 0.038 CID_154700151 | CID_154700151 | |
| 0.016 | 0.064 | 0.172 | NMDA 2D receptor antagonist | 0.172 0.003 CID_154700151 | CID_154700151 | |
| 0.093 | 0.155 | 0.347 | Diuretic | 0.347 0.017 CID_154700151 | CID_154700151 | |
| 0.013 | 0.083 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.016 CID_154700151 | CID_154700151 | |
| 0.018 | 0.089 | 0.091 | Dopamine D2 agonist | 0.091 0.012 CID_154700151 | CID_154700151 | |
| 0.018 | 0.142 | 0.083 | Leukocyte elastase inhibitor | 0.083 0.012 CID_154700151 | CID_154700151 | |
| 0.027 | 0.152 | 0.129 | Factor IXa inhibitor | 0.129 0.005 CID_154700151 | CID_154700151 | |
| 0.059 | 0.19 | 0.258 | Multidrug resistance-associated protein 1 inhibitor | 0.258 0.005 CID_154700151 | CID_154700151 | |
| 0.044 | 0.186 | 0.076 | Chymotrypsin inhibitor | 0.076 0.06 CID_154700151 | CID_154700151 | |
| 0.017 | 0.165 | 0.963 | Cholecystokinin B agonist | 0.963 0.001 CID_154700151 | CID_154700151 | |
| 0.055 | 0.213 | 0.143 | Nav1.4 sodium channel blocker | 0.143 0.037 CID_154700151 | CID_154700151 | |
| 0.012 | 0.172 | 0.054 | Carbonic anhydrase inhibitor | 0.054 0.051 CID_154700151 | CID_154700151 | |
| 0.02 | 0.19 | 0.253 | Selectin antagonist | 0.253 0.008 CID_154700151 | CID_154700151 | |
| 0.067 | 0.241 | 0.421 | Dual specificity phosphatase 3 inhibitor | 0.421 0.012 CID_154700151 | CID_154700151 | |
| 0.005 | 0.184 | 0.851 | Cholecystokinin A agonist | 0.851 0.001 CID_154700151 | CID_154700151 | |
| 0.069 | 0.27 | 0.196 | Antimitotic | 0.196 0.086 CID_154700151 | CID_154700151 | |
| 0.005 | 0.217 | 0.866 | Cholecystokinin agonist | 0.866 0.001 CID_154700151 | CID_154700151 | |
| 0.007 | 0.25 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 CID_154700151 | CID_154700151 | |
| 0.017 | 0.287 | 0.064 | Neuraminidase (influenza) inhibitor | 0.064 0.044 CID_154700151 | CID_154700151 | |
| 0.009 | 0.285 | 0.057 | Factor XIa inhibitor | 0.057 0.014 CID_154700151 | CID_154700151 | |
| 0.005 | 0.323 | 0.06 | Factor XI inhibitor | 0.06 0.007 CID_154700151 | CID_154700151 | |
| 0.012 | 0.341 | 0.109 | Elastase inhibitor | 0.109 0.008 CID_154700151 | CID_154700151 | |
| 0.01 | 0.351 | 0.347 | NMDA 2B receptor antagonist | 0.347 0.004 CID_154700151 | CID_154700151 | |
| 0.046 | 0.398 | 0.306 | Platelet adhesion inhibitor | 0.306 0.032 CID_154700151 | CID_154700151 | |
| 0.012 | 0.371 | 0.036 | Toll-Like receptor 4 agonist | 0.036 0.006 CID_154700151 | CID_154700151 | |
| 0.011 | 0.388 | 0.055 | H+/K+-transporting ATPase inhibitor | 0.055 0.03 CID_154700151 | CID_154700151 | |
| 0.024 | 0.488 | 0.505 | Anticoagulant | 0.505 0.01 CID_154700151 | CID_154700151 | |
| 0.01 | 0.552 | 0.061 | MAP kinase kinase 10 inhibitor | 0.061 0.057 CID_154700151 | CID_154700151 | |
| 0.016 | 0.59 | 0.136 | Thrombolytic | 0.136 0.094 CID_154700151 | CID_154700151 | |
| 0.003 | 0.638 | 0.429 | Cholecystokinin B antagonist | 0.429 0.003 CID_154700151 | CID_154700151 | |
| 0.003 | 0.645 | 0.427 | Cholecystokinin antagonist | 0.427 0.003 CID_154700151 | CID_154700151 | |
| 0.003 | 0.662 | 0.532 | Cholecystokinin A antagonist | 0.532 0.003 CID_154700151 | CID_154700151 | |
| 0.006 | 0.714 | 0.085 | Thrombin inhibitor | 0.085 0.037 CID_154700151 | CID_154700151 | |
| 0.018 | 0.733 | 0.236 | Angiogenesis inhibitor | 0.236 0.133 CID_154700151 | CID_154700151 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |